Publications

Export 10 results:
Auteur Title [ Type(Desc)] Année
Filtres: Auteur is Leuzy, Antoine  [Enlever les filtres]
Journal Article
Zimmer ER, Parent MJ, Souza DG, Leuzy A, Lecrux C, Kim H-I, Gauthier S, Pellerin L, Hamel E, Rosa-Neto P.  2017.  [(18)F]FDG PET signal is driven by astroglial glutamate transport.. Nat Neurosci. 20(3):393-395.
Zimmer ERigon, Leuzy A, Gauthier S, Rosa-Neto P.  2014.  Developments in Tau PET Imaging.. Can J Neurol Sci. 41(5):547-53.
Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A et al..  2015.  Epistasis analysis links immune cascades and cerebral amyloidosis.. J Neuroinflammation. 12:227.
Leuzy A, Zimmer ERigon, Bhat V, Rosa-Neto P, Gauthier S.  2014.  Imaging biomarkers for amyloid: a new generation of probes and what lies ahead.. Int Psychogeriatr. 26(5):703-7.
Zimmer ER, Parent MJ, Leuzy A, Aliaga A, Aliaga A, Moquin L, Schirrmacher ES, Soucy J-P, Skelin I, Gratton A et al..  2015.  Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone.. J Cereb Blood Flow Metab. 35(7):1169-74.
[Anonymous].  2020.  The impact of demographic, clinical, genetic, and imaging variables on tau PET status.. Eur J Nucl Med Mol Imaging.
Leuzy A, Zimmer ERigon, Dubois J, Pruessner J, Cooperman C, Soucy J-P, Kostikov A, Schirmaccher E, Désautels R, Gauthier S et al..  2015.  In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.. Brain Struct Funct.
Zimmer ERigon, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P.  2014.  In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.. Transl Neurodegener. 3(1):6.
Zimmer ERigon, Leuzy A, Benedet ALessa, Breitner JCS, Gauthier S, Rosa-Neto P.  2014.  Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.. J Neuroinflammation. 11:120.
Leuzy A, Zimmer ERigon, Heurling K, Rosa-Neto P, Gauthier S.  2014.  Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.. Amyloid. 21(3):143-8.